Montag & Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History

Montag & Associates’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.1K	Hold	80	–	–	﹤0.01%	703
2025 Q4	$13.6K	Hold	80	–	–	﹤0.01%	739
2025 Q3	$10.5K	Hold	80	–	–	﹤0.01%	752
2025 Q2	$8.49K	Hold	80	–	–	﹤0.01%	759
2025 Q1	$9.93K	Hold	80	–	–	﹤0.01%	793
2024 Q4	$9.85K	Hold	80	–	–	﹤0.01%	786
2024 Q3	$8.91K	Hold	80	–	–	﹤0.01%	820
2024 Q2	$8.54K	Hold	80	–	–	﹤0.01%	783
2024 Q1	$9.63K	Hold	80	–	–	﹤0.01%	767
2023 Q4	$9.84K	Hold	80	–	–	﹤0.01%	776
2023 Q3	$10.4K	Hold	80	–	–	﹤0.01%	735
2023 Q2	$9.92K	Hold	80	–	–	﹤0.01%	756
2023 Q1	$11.7K	Sell	80 -9	-10%	-$1.33K	﹤0.01%	728
2022 Q4	$14.2K	Buy	89 +9	+11%	+$1.32K	﹤0.01%	696
2022 Q3	$11K	Hold	80	–	–	﹤0.01%	726
2022 Q2	$12K	Hold	80	–	–	﹤0.01%	686
2022 Q1	$12K	Hold	80	–	–	﹤0.01%	709
2021 Q4	$10K	Hold	80	–	–	﹤0.01%	725
2021 Q3	$10K	Hold	80	–	–	﹤0.01%	728
2021 Q2	$14K	Hold	80	–	–	﹤0.01%	696
2021 Q1	$13K	Hold	80	–	–	﹤0.01%	710
2020 Q4	$13K	Buy	+80	New	+$11.9K	﹤0.01%	685

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Montag & Associates's JAZZ Position: Q1 2026 in Review

Montag & Associates held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 80 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #703.

Montag & Associates first reported a position in JAZZ in Q4 2020 and has held it in 22 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Montag & Associates held 80 shares of Jazz Pharmaceuticals worth $15.1K as of Q1 2026.
Montag & Associates left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
Jazz Pharmaceuticals made up ﹤0.01% of Montag & Associates's portfolio in Q1 2026, its #703 holding.
Montag & Associates first reported a position in Jazz Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.